-
Pfizer hikes U.S. prices of 91 drugs
biospectrumasia
June 13, 2017
This is the second time this year that Pfizer has implemented a series of wholesale price increases. The medications include best-selling drugs like Viagra, the erectile dysfunction treatment, and Lyrica for nerve pain.
-
Pfizer receives FDA Fast Track designation for tafamidis for transthyretin cardiomyopathy
worldpharmanews
June 07, 2017
Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to tafamidis...
-
Pfizer’s Trumenba to challenge GlaxoSmithKline's Bexsero with EU nod
fiercepharma
June 01, 2017
Meningococcal group B vaccine Bexsero has been helping drive revenue growth for GlaxoSmithKline, but now, with a European approval, Pfizer’s Trumenba is set to challenge it in that lucrative market.
-
Pfizer collaboration to reduce injectable contraceptive price
europeanpharmaceuticalreview
May 26, 2017
“New innovations in contraceptive technology are needed to expand the number of methods available to women and adolescents so they can take charge of their health and their futures.”
-
Sangamo and Pfizer to collaborate on Haemophilia A gene therapy
europeanpharmaceuticalreview
May 18, 2017
Sangamo Therapeutics and Pfizer have announced an exclusive, global collaboration and license agreement for the development and commercialisation of gene therapy programs for Haemophilia A.
-
Pfizer’s 13-valent PCV selected in India’s immunisation programme
pharmaceutical-technology
May 16, 2017
Pharmaceutical firm Pfizer’s 13-valent Pneumococcal Conjugate Vaccine (PCV 13) has been selected in India’s immunisation programme in selected states.
-
Is Pfizer to buy BMS? CEO Read hinted at the possibility
en-cphi.cn
May 12, 2017
Is the industry giant Pfizer planning to make another acquisition?
-
Pfizer inks deal with Sangmo for Heamophilia A gene therapy
biospectrumasia
May 12, 2017
There are approximately 16,000 patients in the U.S. and more than 150,000 worldwide with Hemophilia A
-
Pfizer, Merck KGaA join with cancer vaccine biotech Vaximm for Bavencio combo studies
fiercepharma
May 10, 2017
Vaximm signed up with Pfizer and Merck KGaA to test its cancer vaccine with Bavencio in glioblastoma and metastatic colorectal cancer.
-
Pfizer offers Ibrance free to the NHS during NICE appraisal
pharmatimes
May 08, 2017
Pfizer is to offer its breast cancer drug Ibrance free to the NHS while cost regulators decide whether it should be routinely funded in the UK.